Physician profile
Louis Cunningham
NPI 1306885447
$2,629.95
in general payments reported to CMS, 2019-2025
26 companies · $493 in 2025
The $493 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $288 · 2020: $284 · 2021: $504 · 2022: $554 · 2023: $417 · 2024: $90.39 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $380.18 | 2022-2025 | Amvuttra, Onpattro |
| Novartis Pharmaceuticals Corporation | $330.47 | 2019-2024 | |
| Amgen INC. | $325.36 | 2020-2025 | Repatha |
| Merck Sharp & Dohme LLC | $301.40 | 2021-2025 | Verquvo, Winrevair |
| Astrazeneca Pharmaceuticals LP | $250.66 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $249.99 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $141.40 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $121.07 | 2022-2025 | Camzyos, Eliquis |
| Cardiovascular Systems INC. | $84.98 | 2019-2020 | |
| Boston Scientific Corporation | $58.38 | 2019-2024 | Watchman Flx |
| Medtronic Vascular, INC. | $45.38 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.14 | 2023 | Jardiance |
| Philips North America LLC | $41.73 | 2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Abbott Laboratories | $36.67 | 2021-2023 | Diamondback Peripheral |
| Arbor Pharmaceuticals, INC. | $33.53 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $27.25 | 2025 | Inspire |
| Astellas Pharma US INC | $26.68 | 2021 | |
| Esperion Therapeutics, INC. | $19.95 | 2020 | |
| G Medical Diagnostic Services, INC. | $16.96 | 2020 | |
| Biotronik INC. | $15.70 | 2019 | |
| Pfizer INC. | $14.87 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.70 | 2025 | |
| Medtronic, INC. | $13.17 | 2021 | |
| Ge Healthcare | $12.81 | 2021 | |
| Irhythm Technologies, INC. | $12.52 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.